Wednesday, September 02, 2015

UTSA, UT Health Science Center announce Center for Innovation in Drug Discovery

UTSA researchers

UTSA representatives in the partnership are Doug Frantz, CIDD co-director and Stanton McHardy, CIDD medicinal chemistry core director

Share this Story

(Sept. 11, 2012) -- Taking homegrown discoveries -- research findings observed in laboratories in San Antonio -- and turning them into drugs to treat disease is the focus of the Center for Innovation in Drug Discovery (CIDD) being built at both The University of Texas at San Antonio (UTSA) and the UT Health Science Center San Antonio.

Doug E. Frantz and Stanton McHardy in the UTSA Department of Chemistry are building a medicinal chemistry core facility in labs on the UTSA Main Campus. Frantz, the CIDD co-director, and McHardy, the CIDD medicinal chemistry core director, have nearly 20 years of experience between them with Merck and Pfizer.

"Several top-tier universities have established centers dedicated to the discovery and development of new drugs that will treat devastating human diseases," said Frantz, whose vision was a driving force in the center's formation. "The most successful of these enterprises have included faculty and research staff who bring pharmaceutical industry experience to the table. Both Dr. McHardy and I have worked on U.S. Food and Drug Administration-approved drugs during our professional careers, and we believe these experiences will greatly benefit the CIDD here in San Antonio."

CIDD Co-Director Bruce Nicholson, professor and chair of biochemistry in the School of Medicine at the UT Health Science Center, and Matthew Hart, the CIDD high-throughput screening director, are developing a high-content/high-throughput screening core facility that will enable researchers to rapidly sift through thousands of potentially therapeutic compounds. This will be housed at the Joe R. and Teresa Lozano Long Campus of the Health Science Center starting in November, but the high-content imaging screens are already operational in temporary laboratories at the Texas Research Park.

"In order to identify small molecules or peptides that can bind to a protein or impact a cellular process that could represent a good target for disease therapy, you need the capacity to test and compare thousands of compounds to see which one works the best," said Nicholson. "The high-throughput and high-content screening facility will bring this capability to the San Antonio research community. We will offer not only biochemical screens to test how well potential drugs bind their targets, but we will also provide screens of live cells to assess compound effects on cell behavior."

The CIDD is designed to help develop drugs out of original discoveries made at the Health Science Center and UTSA to treat all forms of disease and infection. "San Antonio has always been among the top Phase I centers in the country," said Nicholson. "But, what we've not done very much is take homegrown discoveries and turn them into the next-generation drugs. This center is designed to facilitate that."

This is particularly true in the case of cancer research, where for many years most of the new drugs tested at the Cancer Therapy and Research Center did not originate from the Health Science Center.

Phase I cancer studies are conducted to demonstrate a novel agent's safety in patients whose tumors are not responding to existing therapies. Phase II and further studies define optimum use of the medications.

The earliest phases of pre-clinical drug discovery can take many forms. Structural biology studies at the Health Science Center have identified many protein targets for therapy in Alzheimer's disease, Parkinson's disease, diabetes, cancer and other disorders, and teams are in the process of obtaining high-resolution structures of these targets. This can be very effective in guiding the design of new drugs.

In other cases, scientists in many departments at the Health Science Center and UTSA have identified specific cellular processes central to the development of a disease that present ideal targets for therapy and in some cases have identified compounds or novel plant extracts that can affect them.

"The pre-clinical advancement of new small molecule drug-like candidates requires a multi-disciplinary approach and a diverse platform of research support," said McHardy. "The overall strategy for the CIDD at UTSA and the Health Science Center is to pull the successful strategies used in the pharmaceutical and biotechnology sectors and provide them to researchers to help advance small-molecule therapeutics for truly novel pharmacological targets and the treatment of numerous diseases."

Education is another key component of the center. Currently, UTSA undergraduate and graduate students in Frantz's laboratory are conducting research on breast cancer, prostate cancer and regenerative medicine involving stem cell differentiation, and addressing diabetes and neurodegenerative diseases such as Alzheimer's and Parkinson's diseases. Additionally, many graduate students at the Health Science Center are involved in designing therapeutic strategies to combat these same diseases. New courses in the emerging area of academic biomedical research are being developed and could lay the groundwork for a future graduate training program between these institutions.

The new center is expected to help with recruitment of outstanding faculty and graduate students to San Antonio in the field of medicinal chemistry and drug discovery. "Fruitful interactions are also anticipated between the CIDD and the UT Health Science Center's Institute for Integration of Medicine and Science (IIMS)," said IIMS Director Robert Clark, M.D. "Accelerating the pathway of drug discovery and development from the laboratory bench to initial testing in patients is one of our key objectives, and we are very enthusiastic about the impact that the CIDD will have in this area."

"Texas is seeing burgeoning development in biotech and drug discovery, and this new initiative will allow our students to have research opportunities that could eventually have global impacts on therapeutic treatments for patients," Frantz said. "I think this center will be a huge attraction and recruiting tool for us to show outstanding chemists why UTSA, working alongside the UT Health Science Center, is on a phenomenal trajectory to reach Tier One status."

State and private funding of $3.5 million is launching the CIDD. Support from the Texas Legislature is enabling renovation of existing research space, and the Legislature also provided funds through the San Antonio Life Sciences Institute. A generous private gift will be announced soon by UTSA.

------------------------------

The University of Texas at San Antonio is one of the largest of nine academic universities and six health institutions in the UT System. As a multicultural institution, UTSA aims to be a national research university providing access to educational excellence and preparing citizen leaders for the global environment. UTSA serves nearly 31,000 students in 135 degree programs in the colleges of architecture, business, education and human development, engineering, honors, liberal and fine arts, public policy, sciences and the Graduate School. Founded in 1969, UTSA is an intellectual and creative resource center and a socioeconomic development catalyst for Texas and beyond.

The University of Texas Health Science Center at San Antonio, one of the country's leading health sciences universities, ranks in the top 3 percent of all institutions worldwide receiving federal funding. Research and other sponsored program activity totaled $231 million in fiscal year 2011. The university's schools of medicine, nursing, dentistry, health professions and graduate biomedical sciences have produced approximately 28,000 graduates. The $736 million operating budget supports eight campuses in San Antonio, Laredo, Harlingen and Edinburg.

 

 

Did You Know?

Football standouts make Roadrunner history

For Ashaad Mabry and Triston Wade, football is not just a passing fancy. Both players were part of the UTSA football program almost from the beginning. When UTSA opens the 2015 season Thursday at Arizona, it will be the first time the Roadrunners take the field without them. But Mabry and Wade will still be playing football; their uniforms will just be a different color.

Mabry, a defensive tackle from San Antonio's MacArthur High School, was an honorable mention All-Conference USA selection his final two seasons as a Roadrunner and second among the team's defensive linemen with 49 tackles last year. Wade, a defensive back from Tyler, was the most decorated player in school history. He was a semifinalist for the 2014 Jim Thorpe Award – for the nation's top defensive back – a three-time all-conference honoree and two-year team captain who set a school record of 293 tackles in his career. Both men had outstanding college careers that allowed them to make UTSA history.

Did you know? Mabry and Wade both agreed to terms as undrafted free agents with the New Orleans Saints and Seattle Seahawks, respectively, becoming the first UTSA players to move to the professional ranks.

Read More »
Events
Sept. 7, All Day

Labor Day Holiday

All campuses will be closed for the Labor Day holiday.
All Campuses

Sept. 9, 5:30 p.m.

Architecture Connects

The UTSA College of Architecture, Construction and Planning’s 2015-16 Speaker Series begins Sept. 9 with Toshiko Mori, the Robert P. Hubbard Professor in the Practice of Architecture at the Harvard University Graduate School of Design and principal of Manhattan-based Toshiko Mori Architect.
Buena Vista Building Aula Canaria (BV 1.328), Downtown Campus

Sept. 12, 11 a.m.

UTSA Football vs. Kansas State

Cheer on the UTSA Roadrunners at their home-opener against the Kansas State Wildcats.
Alamodome, 100 Montana St.

Sept. 15, 5:30 - 7 p.m.

Changing the Conversation: Recovery Works!

As part of National Recovery Month, a panel of substance abuse practitioners and members of the recovery community will discuss issues related to substance abuse treatment and recovery.
Durango Building 1.124 (DB 1.124), Downtown Campus

Sept. 24, 6 p.m.

The Power of Story in the Landscape of Memory and Identity

The UTSA College of Education and Human Development will host award-winning children’s author and illustrator Yuyi Morales. Morales will share personal stories that have influenced her work as an author and illustrator.
Buena Vista Building Aula Canaria (BV 1.328), Downtown Campus

Oct. 5, 9 a.m. - 3 p.m.

Civic Engagement Summit

This summit is an opportunity to showcase and share the variety of community engagement activities of UTSA students, faculty, and staff. The summit is currently accepting proposals for poster presentations. The Call for Posters deadline is Friday, Sept. 11.
University Center Denman Room (2.01.28), Main Campus


Other Calendars
» UTSA Events | » Academic | » Institute of Texan Cultures

Submit an Event


Meet a Roadrunner

Teja Guda '08 is an engineer on the cutting edge

Biomedical engineering alum and professor is working to regenerate tissue

UTSA's Mission

The University of Texas at San Antonio is dedicated to the advancement of knowledge through research and discovery, teaching and learning, community engagement and public service. As an institution of access and excellence, UTSA embraces multicultural traditions and serves as a center for intellectual and creative resources as well as a catalyst for socioeconomic development and the commercialization of intellectual property - for Texas, the nation and the world.

UTSA's Vision

To be a premier public research university, providing access to educational excellence and preparing citizen leaders for the global environment.

UTSA's Core Values

We encourage an environment of dialogue and discovery, where integrity, excellence, inclusiveness, respect, collaboration and innovation are fostered.

Connect with UTSA News

       


Related Links

Back to Top

2015 © The University of Texas at San Antonio  |  Produced by University Communications and Marketing